JAMES TREACE - 20 Dec 2021 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for James T. Treace
Issuer symbol
TMCI
Transactions as of
20 Dec 2021
Net transactions value
-$493,345
Form type
4
Filing time
22 Dec 2021, 18:03:33 UTC
Previous filing
17 Dec 2021
Next filing
27 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $246,587 -15,719 -1.1% $15.69 1,413,227 20 Dec 2021 By J&A Group LLC F1, F2, F4
transaction TMCI Common Stock Sale $6,520 -400 -0.03% $16.30 1,412,827 20 Dec 2021 By J&A Group LLC F1, F3, F4
transaction TMCI Common Stock Other $0 -406,183 -29% $0.000000 1,006,644 20 Dec 2021 By J&A Group LLC F4, F5
transaction TMCI Common Stock Other $0 -406,183 -40% $0.000000 600,461 20 Dec 2021 By J&A Group LLC F4, F5
transaction TMCI Common Stock Other $0 -270,789 -45% $0.000000 329,672 20 Dec 2021 By J&A Group LLC F4, F5
transaction TMCI Common Stock Other $0 -270,789 -82% $0.000000 58,883 20 Dec 2021 By J&A Group LLC F4, F5
transaction TMCI Common Stock Other $0 +406,183 +68% $0.000000 1,006,183 20 Dec 2021 By spouse F6
transaction TMCI Common Stock Other $0 +406,183 +38% $0.000000 1,461,441 20 Dec 2021 Direct F6
transaction TMCI Common Stock Sale $217,286 -13,478 -23% $16.12 45,405 21 Dec 2021 By J&A Group LLC F1, F4, F7
transaction TMCI Common Stock Sale $22,953 -1,403 -3.1% $16.36 44,002 21 Dec 2021 By J&A Group LLC F1, F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.205 to $16.10 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.275 to $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.
F5 Pro rata distribution from J&A Group, LLC to member.
F6 Includes pro rata distribution from J&A Group, LLC.
F7 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.38 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.